In other countries
The same active substances on other registers, the same brand first.
- Quinine SulfateUnited States · 324MG · capsule · Teva PharmsSame form
- QualaquinUnited States · 324MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · capsule · Sun Pharm IndustriesSame form
- Lqfex - Sulfato de QuininaBrazil · Laboratório Químico Farmacêutico do ExércitoSame substance
- Ivb- Sulfato de QuininaBrazil · Instituto Vital Brazil S/ASame substance
- PlasquininBrazil · Cristália Produtos Químicos Farmacêuticos Ltda.Same substance
- Chinina Cloridrato Agenzia Industrie DifesaItaly · Concentrato per soluzione per infusione · Agenzia Industrie Difesa - Stabilimento Chimico Farmaceutico MilitareSame substance
- Chinina Cloridrato Galenica SeneseItaly · Soluzione iniettabile · Industria Farmaceutica Galenica Senese S.R.L.Same substance
- Chinina Cloridrato S.A.L.F.Italy · Concentrato per soluzione per infusione · S.A.L.F. SPA Laboratorio FarmacologicoSame substance
- A-QS 200 Kininesulfaat-dihydraat 200 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · ACE Pharmaceuticals B.V.Same substance
- AnyNew Zealand · Inj 60 mg per ml, 10 ml ampouleSame substance
- Chininum sulphuricumUnited StatesSame substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Quinine
- Strength
- 200 MG
- Dosage form
- Capsule
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 31 Dec 1966
- Registration
- DIN 00021008
- Marketing authorisation holder
- Teva Canada Limited
- ATC code
- P01BC01
- Supply
- PRESCRIPTION